These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol. Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880 [TBL] [Abstract][Full Text] [Related]
23. Home-delivered attention bias modification training via smartphone to improve attention control in sub-clinical generalized anxiety disorder: A randomized, controlled multi-session experiment. Teng MH; Hou YM; Chang SH; Cheng HJ J Affect Disord; 2019 Mar; 246():444-451. PubMed ID: 30599367 [TBL] [Abstract][Full Text] [Related]
24. Attention bias modification training under working memory load increases the magnitude of change in attentional bias. Clarke PJF; Branson S; Chen NTM; Van Bockstaele B; Salemink E; MacLeod C; Notebaert L J Behav Ther Exp Psychiatry; 2017 Dec; 57():25-31. PubMed ID: 28257926 [TBL] [Abstract][Full Text] [Related]
25. Bias-contingent attention bias modification and attention control training in treatment of PTSD: a randomized control trial. Lazarov A; Suarez-Jimenez B; Abend R; Naim R; Shvil E; Helpman L; Zhu X; Papini S; Duroski A; Rom R; Schneier FR; Pine DS; Bar-Haim Y; Neria Y Psychol Med; 2019 Oct; 49(14):2432-2440. PubMed ID: 30415648 [TBL] [Abstract][Full Text] [Related]
26. A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study. Seki Y; Nagata S; Shibuya T; Yoshinaga N; Yokoo M; Ibuki H; Minamitani N; Kusunoki M; Inada Y; Kawasoe N; Adachi S; Yoshimura K; Nakazato M; Iyo M; Nakagawa A; Shimizu E BMC Res Notes; 2016 Oct; 9(1):458. PubMed ID: 27717407 [TBL] [Abstract][Full Text] [Related]
27. Attention Bias Modification Treatment for Adolescents With Major Depression: A Randomized Controlled Trial. Yang W; Zhang JX; Ding Z; Xiao L J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):208-18.e2. PubMed ID: 26903254 [TBL] [Abstract][Full Text] [Related]
28. Context matters: The role of subjective arousal during Attentional Bias Modification targeting socially anxious students. Nuijs MD; Larsen H; Bögels SM; Wiers RW; Salemink E J Behav Ther Exp Psychiatry; 2020 Sep; 68():101545. PubMed ID: 32171997 [TBL] [Abstract][Full Text] [Related]
35. Statistical learning as a predictor of attention bias modification outcome: A preliminary study among socially anxious patients. Alon Y; Arad G; Pine DS; Bar-Haim Y Behav Res Ther; 2019 Jan; 112():36-41. PubMed ID: 30496885 [TBL] [Abstract][Full Text] [Related]
36. Predictors and moderators of internet- and group-based cognitive behaviour therapy for panic disorder. El Alaoui S; Hedman E; Ljótsson B; Bergström J; Andersson E; Rück C; Andersson G; Lindefors N PLoS One; 2013; 8(11):e79024. PubMed ID: 24244406 [TBL] [Abstract][Full Text] [Related]
37. Threat expectancy bias and treatment outcome in patients with panic disorder and agoraphobia. Duits P; Klein Hofmeijer-Sevink M; Engelhard IM; Baas JMP; Ehrismann WAM; Cath DC J Behav Ther Exp Psychiatry; 2016 Sep; 52():99-104. PubMed ID: 27061246 [TBL] [Abstract][Full Text] [Related]
38. Attention bias modification in depression: A randomized trial using a novel, reward-based, eye-tracking approach. Woolridge SM; Harrison GW; Best MW; Bowie CR J Behav Ther Exp Psychiatry; 2021 Jun; 71():101621. PubMed ID: 33202263 [TBL] [Abstract][Full Text] [Related]
39. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia. Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445 [TBL] [Abstract][Full Text] [Related]
40. Inhibition moderates the effect of attentional bias modification for reducing residual depressive symptoms: A randomized sham-controlled clinical trial. Bø R; Kraft B; Skilbrei A; Jonassen R; Harmer CJ; Landrø NI J Behav Ther Exp Psychiatry; 2024 Dec; 85():101982. PubMed ID: 39111231 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]